CHST9 Rs1436904 Genetic Variant Contributes to Prognosis of Triple-Negative Breast Cancer

Scientific Reports - United Kingdom
doi 10.1038/s41598-017-12306-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

CD155 Contributes to the Mesenchymal Phenotype of Triple‐negative Breast Cancer

Cancer Science
Cancer ResearchMedicineOncology
2020English

Triple-Negative Breast Cancer

2018English

ECT2 Associated to PRICKLE1 Are Poor-Prognosis Markers in Triple-Negative Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
2019English

T‑cadherin Is Associated With Prognosis in Triple‑negative Breast Cancer

Oncology Letters
Cancer ResearchOncology
2017English

Identification of Prognosis-Relevant Subgroups in Patients With Chemoresistant Triple-Negative Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2013English

Triple Negative Breast Cancer: Breast Cancer Research in Evolution

Breast Disease
MedicineCancer ResearchOncology
2011English

MiRNAs Predict the Prognosis of Patients With Triple Negative Breast Cancer: A Meta-Analysis

PLoS ONE
Multidisciplinary
2017English

Triple Negative Breast Cancer: Heterogenous Disease

REVIEWS IN ONCOLOGY
2013English

A Review of Triple-Negative Breast Cancer

Cancer Control
MedicineOncologyHematology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy